Cargando…
Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2021
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273324/ https://www.ncbi.nlm.nih.gov/pubmed/35833053 http://dx.doi.org/10.1055/s-0041-1731911 |
| _version_ | 1784745047858610176 |
|---|---|
| author | Cyriac, Sanju Toms, Ajith Thomas, Sunitha |
| author_facet | Cyriac, Sanju Toms, Ajith Thomas, Sunitha |
| author_sort | Cyriac, Sanju |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9273324 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Thieme Medical and Scientific Publishers Pvt. Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92733242022-07-12 Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma Cyriac, Sanju Toms, Ajith Thomas, Sunitha South Asian J Cancer Thieme Medical and Scientific Publishers Pvt. Ltd. 2021-11-11 /pmc/articles/PMC9273324/ /pubmed/35833053 http://dx.doi.org/10.1055/s-0041-1731911 Text en MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
| spellingShingle | Cyriac, Sanju Toms, Ajith Thomas, Sunitha Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma |
| title | Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma |
| title_full | Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma |
| title_fullStr | Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma |
| title_full_unstemmed | Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma |
| title_short | Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma |
| title_sort | durable response with single-agent pembrolizumab in a patient with metastatic melanoma |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273324/ https://www.ncbi.nlm.nih.gov/pubmed/35833053 http://dx.doi.org/10.1055/s-0041-1731911 |
| work_keys_str_mv | AT cyriacsanju durableresponsewithsingleagentpembrolizumabinapatientwithmetastaticmelanoma AT tomsajith durableresponsewithsingleagentpembrolizumabinapatientwithmetastaticmelanoma AT thomassunitha durableresponsewithsingleagentpembrolizumabinapatientwithmetastaticmelanoma |